Case Report
Accepted on 03 Mar 2026
Case Report: primary gallbladder undifferentiated small round cell sarcomas treated with gemcitabine, paclitaxel, bevacizumab and pembrolizumab achieved remarkable tumor regression
in Cancer Immunity and Immunotherapy